Calcium in the treatment of diarrhoea and hyperoxaluria after jejunoileal bypass for obesity.
Fourteen patients with jejunoileal bypass for obesity were treated for one week with a calcium supplement of 3g daily. During this period diarrhoea was significantly (P < 0.005) reduced by 23 per cent (97 per cent confidence limits: 7-46 per cent). Ten of the patients had hyperoxaluria (median value 961 mumol/24 h; range 633-2742 mumol/24 h). The treatment with calcium significantly (P < 0.005) decreased the concentration of oxalate in urine by 23 per cent (98 per cent confidence limits: -5-+54 per cent). The calcium supplement did not increase urinary calcium-excretion rate or albumin-corrected serum calcium.
D000328:Adult; D002118:Calcium / Q000378:metabolism / Q000627:therapeutic use*; D003967:Diarrhea / Q000188:drug therapy*; D005243:Feces / Q000032:analysis; D006801:Humans; D007082:Ileum / Q000601:surgery*; D007583:Jejunum / Q000601:surgery*; D008875:Middle Aged; D009765:Obesity / Q000628:therapy*; D010070:Oxalates / Q000652:urine*
D010070:Oxalates; D002118:Calcium